Cleared Traditional

K832263 - FITC GOAT ANTI-HUMAN IGA A CHAIN

K832263 is an FDA 510(k) clearance for FITC GOAT ANTI-HUMAN IGA A CHAIN, manufactured by Gelco Diagnostics, Inc.. The device is a Class 2 Immunology device with product code CZP cleared through the Traditional 510(k) pathway after a 123-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 1983
Decision
123d
Days
Class 2
Risk

K832263 is an FDA 510(k) clearance for the FITC GOAT ANTI-HUMAN IGA A CHAIN. Classified as Iga, Antigen, Antiserum, Control (product code CZP), Class II - Special Controls.

Submitted by Gelco Diagnostics, Inc. (Walker, US). The FDA issued a Cleared decision on October 31, 1983 after a review of 123 days - within the typical 510(k) review window.

This device falls under the Immunology FDA review panel, regulated under 21 CFR 866.5510 - the FDA immunology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Immunology review framework, consistent with the majority of Class II 510(k) submissions.

FDA 510(k) Submission Details - K832263

510(k) Number K832263 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 30, 1983
Decision Date October 31, 1983
Days to Decision 123 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
18d slower than avg
Panel avg: 105d · This submission: 123d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CZP Device Classification - Class 2, Special Controls

Product Code CZP Iga, Antigen, Antiserum, Control
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.5510
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Immunology devices follow this clearance model.

Regulatory Peers - CZP Iga, Antigen, Antiserum, Control

All 51
Devices cleared under the same product code (CZP) and FDA review panel - the closest regulatory comparables to K832263.
CORNING IMMUNOFIXATION SYS
K843614 · Corning Medical & Scientific · Oct 1984
TISSUE-TEK IMMUNOHISTOLOGY KIT IGA/IGG
K842468 · Miles Laboratories, Inc. · Aug 1984
AMER. HISTO-ID SYS PRIMARY IGA 2720-21
K842330 · Bartels Immunodiagnostic Supplies, Inc. · Aug 1984
TIA-IGA REAGENT & CALIBRATOR SETS
K831102 · Worthington Diagnostic Systems · Apr 1983
IMMUNOGLOBULIN CONTROL
K823566 · Syva Co. · Dec 1982
IMMUNOGLOBULIN ASSAYS-IGG, IGA, IGM
K823567 · Syva Co. · Dec 1982